BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1901337)

  • 1. Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi.
    McCabe RE; Meagher SG; Mullins BT
    J Infect Dis; 1991 Apr; 163(4):912-5. PubMed ID: 1901337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
    Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
    J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.
    Torrico F; Heremans H; Rivera MT; Van Marck E; Billiau A; Carlier Y
    J Immunol; 1991 May; 146(10):3626-32. PubMed ID: 1902858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.
    Silva JS; Vespa GN; Cardoso MA; Aliberti JC; Cunha FQ
    Infect Immun; 1995 Dec; 63(12):4862-7. PubMed ID: 7591147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.
    Chaussabel D; Jacobs F; de Jonge J; de Veerman M; Carlier Y; Thielemans K; Goldman M; Vray B
    Infect Immun; 1999 Apr; 67(4):1929-34. PubMed ID: 10085038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
    Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
    Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG; Brownell CE; Russo DM; Silva JS; Grabstein KH; Morrissey PJ
    J Immunol; 1994 Oct; 153(7):3135-40. PubMed ID: 8089491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice.
    McCabe R; Meagher S; Mullins B
    Infect Immun; 1991 May; 59(5):1633-8. PubMed ID: 1902193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma.
    Revelli S; Didoli G; Roggero E; Moreno H; Bernabo J; Wietzerbin J; Bottasso O
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):153-9. PubMed ID: 9825840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
    BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes.
    Aliberti JC; Cardoso MA; Martins GA; Gazzinelli RT; Vieira LQ; Silva JS
    Infect Immun; 1996 Jun; 64(6):1961-7. PubMed ID: 8675294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
    Silva JS; Twardzik DR; Reed SG
    J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.
    Cardillo F; Voltarelli JC; Reed SG; Silva JS
    Infect Immun; 1996 Jan; 64(1):128-34. PubMed ID: 8557330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.